Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Robust outcome data, including the landmark SELECT trial (encompassing over 17,600 participants) and the SUSTAIN-6 trial (3,297 participants), confirmed a statistically significant and clinically meaningful reduction in MACE (Major Adverse Cardiovascular Events) incidence for those treated with semaglutide compared to placebo, showing superior protection in patients with obesity/overweight and established CV disease
Researchers analyzed 13 placebo-controlled studies involving 3,629 patients with a history of heart attack
These plaintiffs say GLP-1 drugs led them to be diagnosed with gastric disorders, liver and pancreatic injuries, bowel conditions, or other injuries
WeightWatchers stock soared Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence
These medications are effective for many patients in Delray Beach and Boca Raton
As a specialist supplier with a focus on peptide technology, we provide HPLC-certified purity of over 99%
